Cardano (ADA) is still an investors’ favorite, with analysts foretelling a bright long-term outlook. Nevertheless, while ADA’s growth prospects are still positive, savvy investors are beginning to turn to other plays for even higher returns. One such project making the headlines is Mutuum Finance (MUTM), a DeFi altcoin with a low price of only $0.035 […]Cardano (ADA) is still an investors’ favorite, with analysts foretelling a bright long-term outlook. Nevertheless, while ADA’s growth prospects are still positive, savvy investors are beginning to turn to other plays for even higher returns. One such project making the headlines is Mutuum Finance (MUTM), a DeFi altcoin with a low price of only $0.035 […]

Cardano Price Prediction: Analysts Target $5 Long-Term, But Mutuum Finance (MUTM) Promises Even Bigger Gains

2025/10/06 23:00
4 min read

Cardano (ADA) is still an investors’ favorite, with analysts foretelling a bright long-term outlook. Nevertheless, while ADA’s growth prospects are still positive, savvy investors are beginning to turn to other plays for even higher returns. One such project making the headlines is Mutuum Finance (MUTM), a DeFi altcoin with a low price of only $0.035 that has already sold over 60% of its Stage 6 presale. The project has attained over $16.85 million and attracted over 16770 unique investors. Mutuum Finance is a project with even greater potential for growth, and one which could certainly outperform ADA as the next bull cycle begins.

Cardano (ADA) Price Prediction

Cardano (ADA) is showing new strength as it bounces back from recent lows of about $0.75 up into the range of $0.85, above its 50-day EMA and re-establishing vital support in the 200-day EMA. Technical analysts indicate that a clear break out above $0.96 may lead to a move into $1.20, with $5 as a longer term target, and breaking below $0.80 will cause further consolidation. 

Institutional trust is on the rise as well, Hashdex has added ADA to its Nasdaq Crypto Index U.S. ETF, expanding regulated capital flows and enhancing its investment appeal. Whale investors have also accumulated 70 million ADA over one week, and Brave’s integration now provides direct ADA access to over 100 million users, boosting adoption and governance participation. As these positive fundamentals come together, ADA’s upside momentum gathers pace, but investors are also diversifying into Mutuum Finance (MUTM) as the latter teases potentially higher returns.

Mutuum Finance Presale Goes Bonkers 

Mutuum Finance is breaking into DeFi with its presale, with over 16,770 investors already drawn in and more than $16.85 million raised so far. Phase 6 of the presale is live at 60% completion and selling MUTM tokens at a price of $0.035 per token. As a gesture of appreciation to its initial investors, the team has organized a $100,000 giveaway, to award 10 lucky individuals $10,000 MUTM tokens each.

Mutuum Finance will also introduce a USD-pegged stablecoin on the Ethereum blockchain. In contrast to bear market-stopping algorithmic stablecoins, the token is non-algorithmic and overcollateralized and will be architected to become price-stable even in bear markets.

Mutuum Finance Announces Lending & Borrowing Protocol 

Mutuum Finance has announced the development of its lending and borrowing protocol as part of its DeFi build-out. The initial version (V1) of the protocol will go live on Sepolia Testnet in Q4 2025 with the highlight features being a liquidity pool, mtToken, debt token, liquidator bot, etc. Lending, borrowing, and providing ETH and USDT as collateral will be available on day 1 for users to feel the first bite of a strong and secure decentralized finance platform.

There is also a risk-adjusted Loan-to-Value (LTV) mechanism within the protocol whereby each asset has its collateral limit determined by its risk factor. That is for facilitating proportionate and arm’s length lending. Apart from safeguarding users in times of adversity, the protocol also has a buffer reserve mechanism whereby riskier assets are allocated more reserves as extra collateral and to subsidize the ecosystem.

Through its expansion via presale, risk management advancements, and openness, Mutuum Finance is emerging as stable, safe, and innovative DeFi.

Cardano (ADA) does have solid long-term potential with analysts eyeing $5, but the bigger opportunity is with Mutuum Finance (MUTM). At just $0.035, with over 16,770 investors and $16.85M+ funded, MUTM’s presale power and imminent DeFi releases potentially offer much more robust returns. For aggressive growth investors, MUTM is the project to watch.

For more information regarding Mutuum Finance (MUTM) please use the following links:

Website: https://mutuum.com/

Linktree: https://linktr.ee/mutuumfinance

Market Opportunity
GAINS Logo
GAINS Price(GAINS)
$0.00764
$0.00764$0.00764
-0.39%
USD
GAINS (GAINS) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26